We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Cello Health Plc | LSE:CLL | London | Ordinary Share | GB00B0310763 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 161.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMCLL
RNS Number : 0162S
Cello Group plc
27 September 2017
27 September 2017
Cello Group plc
("Cello" or the "Company")
Director/PDMR Shareholding
The Company has been notified that on 27 September 2017 Mark Bentley, Group Finance Director, sold and then re-purchased 110,000 ordinary shares of 10 pence each in the Company ("Ordinary Shares"), in order to transfer the Ordinary Shares to Mr Bentley's SIPP. The sale price was 127.50 pence per share and the purchase price was 127.53 pence per share.
The sale and purchase has no effect on the total number of Ordinary Shares held by Mr Bentley and, following this transaction, Mr Bentley remains beneficially and non-beneficially interested in 442,518 Ordinary Shares, representing approximately 0.4 per cent. of the Company's issued ordinary share capital.
The Company has also received notification that on 27 September 2017, Jane Shirley, a director of Cello Health, exercised share options over 20,000 Ordinary Shares for an exercise price of 10 pence per share, and subsequently sold the 20,000 Ordinary Shares for a price of 127 pence per share. In addition, on 26 September 2017, Alistair Shirley, a person closely associated with Jane Shirley, sold 421 Ordinary Shares at a price of 129 pence per share.
Following the above transactions, Jane Shirley and her persons closely associated hold 78,000 Ordinary Shares, representing approximately 0.1% of the Company's issued ordinary share capital.
Enquiries:
Cello Group 020 7812 8460 Mark Scott, Chief Executive Mark Bentley, Finance Director Cenkos Securities 0207 397 8900 Bobbie Hilliam Harry Hargreaves 1 Details of the person discharging managerial responsibilities / person closely associated --- ------------------------------------------------------- a) Name Mark Bentley --- ------------------------- ---------------------------- 2 Reason for the notification --- ------------------------------------------------------- a) Position/status Finance Director --- ------------------------- ---------------------------- b) Initial notification Initial notification /Amendment --- ------------------------- ---------------------------- 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor --- ------------------------------------------------------- a) Name Cello Group plc --- ------------------------- ---------------------------- b) LEI 2138004TZYGZLWQP7N64 --- ------------------------- ---------------------------- 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted --- ------------------------------------------------------- a) Description of Ordinary Shares of 10p each the financial instrument, type of instrument GB00B0310763 Identification code --- ------------------------- ---------------------------- b) Nature of the Sale of Ordinary Shares transaction --- ------------------------- ---------------------------- c) Price(s) and volume(s) Price(s) Volume(s) --------- ---------- 127.50p 110,000 --------- ---------- --- ------------------------- ---------------------------- d) Aggregated information -Aggregated volume 110,000 -Price GBP140,250 --- ------------------------- ---------------------------- e) Date of the transaction 27 September 2017 --- ------------------------- ---------------------------- f) Place of the transaction XLON --- ------------------------- ---------------------------- 1 Details of the person discharging managerial responsibilities / person closely associated --- ------------------------------------------------------- a) Name Mark Bentley --- ------------------------- ---------------------------- 2 Reason for the notification --- ------------------------------------------------------- a) Position/status Finance Director --- ------------------------- ---------------------------- b) Initial notification Initial notification /Amendment --- ------------------------- ---------------------------- 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor --- ------------------------------------------------------- a) Name Cello Group plc --- ------------------------- ---------------------------- b) LEI 2138004TZYGZLWQP7N64 --- ------------------------- ---------------------------- 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted --- ------------------------------------------------------- a) Description of Ordinary Shares of 10p each the financial instrument, type of instrument GB00B0310763 Identification code --- ------------------------- ---------------------------- b) Nature of the Purchase of Ordinary Shares transaction --- ------------------------- ---------------------------- c) Price(s) and volume(s) Price(s) Volume(s) --------- ---------- 127.53p 110,000 --------- ---------- --- ------------------------- ---------------------------- d) Aggregated information -Aggregated volume 110,000 -Price GBP140,283 --- ------------------------- ---------------------------- e) Date of the transaction 27 September 2017 --- ------------------------- ---------------------------- f) Place of the transaction XLON --- ------------------------- ---------------------------- 1 Details of the person discharging managerial responsibilities / person closely associated --- ------------------------------------------------------- a) Name Jane Shirley --- ------------------------- ---------------------------- 2 Reason for the notification --- ------------------------------------------------------- a) Position/status Director of Cello Health --- ------------------------- ---------------------------- b) Initial notification Initial notification /Amendment --- ------------------------- ---------------------------- 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor --- ------------------------------------------------------- a) Name Cello Group plc --- ------------------------- ---------------------------- b) LEI 2138004TZYGZLWQP7N64 --- ------------------------- ---------------------------- 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted --- ------------------------------------------------------- a) Description of Ordinary Shares of 10p each the financial instrument, type of instrument GB00B0310763 Identification code --- ------------------------- ---------------------------- b) Nature of the Exercise of options over transaction Ordinary Shares --- ------------------------- ---------------------------- c) Price(s) and volume(s) Price(s) Volume(s) --------- ---------- 10p 20,000 --------- ---------- --- ------------------------- ---------------------------- d) Aggregated information -Aggregated volume 20,000 -Price GBP2,000 --- ------------------------- ---------------------------- e) Date of the transaction 27 September 2017 --- ------------------------- ---------------------------- f) Place of the transaction Outside trading venue --- ------------------------- ---------------------------- 1 Details of the person discharging managerial responsibilities / person closely associated --- ------------------------------------------------------- a) Name Jane Shirley --- ------------------------- ---------------------------- 2 Reason for the notification --- ------------------------------------------------------- a) Position/status Director of Cello Health --- ------------------------- ---------------------------- b) Initial notification Initial notification /Amendment --- ------------------------- ---------------------------- 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor --- ------------------------------------------------------- a) Name Cello Group plc --- ------------------------- ---------------------------- b) LEI 2138004TZYGZLWQP7N64 --- ------------------------- ---------------------------- 4 Details of the transaction(s): section to
be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted --- ------------------------------------------------------- a) Description of Ordinary Shares of 10p each the financial instrument, type of instrument GB00B0310763 Identification code --- ------------------------- ---------------------------- b) Nature of the Sale of Ordinary Shares transaction --- ------------------------- ---------------------------- c) Price(s) and volume(s) Price(s) Volume(s) --------- ---------- 127p 20,000 --------- ---------- --- ------------------------- ---------------------------- d) Aggregated information -Aggregated volume 20,000 -Price GBP25,400 --- ------------------------- ---------------------------- e) Date of the transaction 27 September 2017 --- ------------------------- ---------------------------- f) Place of the transaction XLON --- ------------------------- ---------------------------- 1 Details of the person discharging managerial responsibilities / person closely associated --- ------------------------------------------------------- a) Name Alistair Shirley --- ------------------------- ---------------------------- 2 Reason for the notification --- ------------------------------------------------------- a) Position/status Person closely associated with Jane Shirley --- ------------------------- ---------------------------- b) Initial notification Initial notification /Amendment --- ------------------------- ---------------------------- 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor --- ------------------------------------------------------- a) Name Cello Group plc --- ------------------------- ---------------------------- b) LEI 2138004TZYGZLWQP7N64 --- ------------------------- ---------------------------- 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted --- ------------------------------------------------------- a) Description of Ordinary Shares of 10p each the financial instrument, type of instrument GB00B0310763 Identification code --- ------------------------- ---------------------------- b) Nature of the Sale of Ordinary Shares transaction --- ------------------------- ---------------------------- c) Price(s) and volume(s) Price(s) Volume(s) --------- ---------- 129p 421 --------- ---------- --- ------------------------- ---------------------------- d) Aggregated information -Aggregated volume 421 -Price GBP543.09 --- ------------------------- ---------------------------- e) Date of the transaction 26 September 2017 --- ------------------------- ---------------------------- f) Place of the transaction XLON --- ------------------------- ----------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHUBVVRBWAKUAR
(END) Dow Jones Newswires
September 27, 2017 11:59 ET (15:59 GMT)
1 Year Cello Health Chart |
1 Month Cello Health Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions